compound · derived
Pembrolizumab
6 trials · 0 approvals
| Trials | 6 |
|---|---|
| Approvals | 0 |
| Phases | Phase 1, Phase 2, Phase 2, Phase 3 |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-28T02:31:58.630Z
- Licence class: internal-only
- Verdict: derived
- Entity id: pembrolizumab
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.